We use cookies. EPF Congress uses cookies to make sure you get the best experience on our website.

The congress' programme

The congress' Programme

The schedule, day by day

View "Registration and lunch" details

Registration and lunch

Registrations and a light lunch to settle into the conference and connect with fellow participants

Time
-
Type
Networking
View "Plenary 1 - COVID-19, 5 years later: have our healthcare systems recovered?" details

Plenary 1 - COVID-19, 5 years later: have our healthcare systems recovered?

While drawing lessons from the COVID-19 pandemic, the aim of the session will be on shaping a forward-looking approach to strengthen Europe’s ability to respond effectively to future health crises without compromising patient safety and continuity of care. The discussion will also focus on recent strategies such as the European Preparedness Union Strategy and the Strategy to support development and procurement of medical countermeasures against public health threats.

With:

  • Dr Ole Johan Bakke, President, Standing Committee of European Doctors (CPME)

  • Marko Korenjak, President, European Liver Patient Association (ELPA)

  • Dr Karine Lacombe, Coordinator, Project 'A European Proactive Adaptive Clinical Trials Network within EU-Responses' (PROACT EU-Response)

  • Oxana Domenti, Representative to the European Union, World Health Organisation (WHO)

Time
-
Type
Plenary
View "Workshop 1-2-3" details

Workshop 1-2-3

Three workshops will be held simunltaneously, please find all details below.

Workshop 1 - AMR preparedness: how healthcare systems and patient organisations can work together

Most players in the healthcare sector are now well aware of the threats posed by antimicrobial resistance. Thus, this session shifts the focus from problem to action. Each speaker will spotlight one of the key solutions to the problem of antimicrobial resistance.

With:

  • Dr Ulrica Dohnhammar, Coordinator, Project 'European partnership on One Health Antimicrobial Resistance' (EUP OHAMR)

  • Danilo Lo Fo Wong, Regional Adviser Control of Antimicrobial Resistance, World Health Organisation (WHO)

  • Borislava Ananieva, Capacity Building Officer and Patient Advocate, European Patients' Forum (EPF)

Workshop 2 - Healthcare delivery, public health, patient care, and the environment: a solvable equation?

Details to be announced soon — stay tuned!

Workshop 3 - Health and wealth: can the EU budget drive a resilient future?

This session invites key stakeholders to explore how health can remain a priority in the next Multiannual Financial Framework (MFF) — and how to ensure it is properly reflected in future EU funding. At a time when geopolitical challenges dominate the narrative, participants will reflect on the need to rethink our narrative to maintain health high on the EU agenda.

With:

  • Florence Berteletti, Secretary General, The European Alcohol Policy Alliance (Eurocare)

  • Marie Morfouace, Project Lead, Project 'Integrated iMMUnoprofiling of large adaptive CANcer patient cohorts' (IMMUcan)

  • Loredana Simulescu, Executive Director, Biomedical Alliance in Europe

Time
-
Type
Workshop
View "Closing remarks" details

Closing remarks

Wrap-up of the day’s highlights and a look ahead to what’s coming on Day 2

Time
-
Type
Plenary
View "Dinner" details

Dinner

Enjoy great conversations and make new connections over a relaxed, sit-down dinner

Time
-
Type
Networking

View "Plenary 2 - Human-centred innovation: rethinking care in the age of digital health and AI" details

Plenary 2 - Human-centred innovation: rethinking care in the age of digital health and AI

While digital innovation and Artificial Intelligence (AI) promise to revolutionise health systems by improving diagnostics, workflows, and access to care, they also raise critical questions about human oversight, trust, and the preservation of empathy in an increasingly automated environment. This session will explore how digital and AI technologies can support more human-centred healthcare systems and how the European Health Data Space (EHDS) can drive responsible innovation, and reinforce patient agency.

With:

  • Donna Henderson, Head of International Engagement, Scottish Government, Digital Health and Care Directorate, International Engagement Team

  • Marco Marsella, Director for Digital, EU4Health and Health Systems modernization, European Commission, Directorate-General for Health and Food Safety (DG SANTE)

  • Bogi Eliasen, Director of Health, Copenhagen Institute for Futures Studies

  • Tomáš Doležal, Chair, Council of Europe, Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)

  • Lara Bloom, Chief Executive Officer, Ehlers-Danos

Time
-
Type
Plenary
View "Workshop 4-5-6" details

Workshop 4-5-6

Three workshops will be held simunltaneously, please find all details below.

Workshop 4 - No one left behind: equity and solidarity in cross-border crisis response

Despite collective efforts, the needs of underrepresented and underserved patients are often overlooked. Patients face barriers including inadequate outreach to marginalised communities, inequitable access to clinical trials and inflexible study designs. This session will explore how principles of equity and solidarity can drive inclusive and effective access to clinical studies in cross-border crisis responses.

With:

  • Maria Dutarte, Executive Director, European Patients' Academy on Therapeutic Innovation (EUPATI)

  • Melanie Hoste, Postdoctoral Researcher, University of Antwerp

  • Pauline Delahaye, Researcher, Vaccination et Lien Social (VLS)

Workshop 5 - Value in crisis: rethinking what matters in health

Healthcare systems are stretched by rising demand, workforce shortages, inflationary pressures, and technological acceleration. Traditional concepts of value, focused mainly on cost-effectiveness and clinical outcomes, are no longer sufficient. This session will make the case for a broader, more inclusive definition of value, one that reflects public health priorities, societal resilience, equity, and the lived experiences of patients.

With:

  • To be announced soon — stay tuned!

Workshop 6 - Addressing access needs through innovative models for pricing and reimbursement

Traditional pricing and reimbursement (P&R) models are facing mounting pressure amid rising public expectations and tightening healthcare budgets. This session will explore how innovative P&R approaches can help ensure that breakthrough health technologies are made accessible in a way that is timely, affordable, and equitable across Europe.

With:

  • Carin uyl de Groot, Professor of Health Technology Assessment, Erasmus University Rotterdam

  • Pedro Facon, Deputy Chief Executive Officer, Institut national d'assurance maladie-invalidité (RIZIV-INAMI)

  • Valérie Paris, Senior Economist and Health Policy Analyst, Organisation for Economic Co-operation and Development (OECD)

Time
-
Type
Workshop
View "Lunch" details

Lunch

Take a break and enjoy a light lunch

Time
-
Type
Networking
View "Plenary 3 - Building a culture of patient-centered innovation" details

Plenary 3 - Building a culture of patient-centered innovation

In a year marked by discussions on the Pharmaceuticals Reform, the European Biotech Act, and the Critical Medicines Act, this session will explore how to holistically involve patients and patient organisations across the entire life sciences ecosystem, from clinical trials and regulatory decisions to health technology assessment and patient experience data.

With:

  • Steffen Thirstrup, Chief Medical Officer, European Medicines Agency (EMA)

  • Monica Otto, Associate Professor of Practice Health Policy, SDA Bocconi School of Management

  • Marco Greco, President, European Patients’ Forum (EPF)

Time
-
Type
Plenary
View "Keynote speech" details

Keynote speech

Wrap-up to reflect on key moments from the event and thank all who made it possible

Time
-
Type
Keynote